TY - JOUR
T1 - An Update on Suprachoroidal Corticosteroid Injections in the Management of Macular Edema
AU - Ismail, Omar Mohammad
AU - Henry, Christopher R.
N1 - Funding Information:
Omar Mohammad Ismail does not have an existing conflict of interest. Christopher R. Henry reports acting as a consultant for Allergan, Alimera, Bausch + Lomb, Clearside Biomedical, and EyePoint. He has received research funding from Clearside Biomedical, EyePoint, and Santen.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022/9
Y1 - 2022/9
N2 - Purpose of Review: In this article, we review the fundamentals and current clinical data regarding suprachoroidal corticosteroid injections for the management of macular edema. Recent Findings: Recently conducted clinical trials have demonstrated both the efficacy, duration, and favorable side effect profile of suprachoroidal injections in managing macular edema due to varying ocular diseases. Summary: A novel and promising drug delivery method with minimal side effects, suprachoroidal injections, appears to be of utility in the medical management of macular edema associated with uveitis, diabetic macular edema, and macular edema resulting from retinal vascular occlusions.
AB - Purpose of Review: In this article, we review the fundamentals and current clinical data regarding suprachoroidal corticosteroid injections for the management of macular edema. Recent Findings: Recently conducted clinical trials have demonstrated both the efficacy, duration, and favorable side effect profile of suprachoroidal injections in managing macular edema due to varying ocular diseases. Summary: A novel and promising drug delivery method with minimal side effects, suprachoroidal injections, appears to be of utility in the medical management of macular edema associated with uveitis, diabetic macular edema, and macular edema resulting from retinal vascular occlusions.
KW - Drug delivery
KW - Macular edema
KW - Suprachoroidal injection
KW - Uveitis
UR - http://www.scopus.com/inward/record.url?scp=85134709813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134709813&partnerID=8YFLogxK
U2 - 10.1007/s40135-022-00291-7
DO - 10.1007/s40135-022-00291-7
M3 - Review article
AN - SCOPUS:85134709813
SN - 2167-4868
VL - 10
SP - 91
EP - 97
JO - Current Ophthalmology Reports
JF - Current Ophthalmology Reports
IS - 3
ER -